Remoxipride
NERVOUS SYSTEM
Also known as: (S)-Remoxipride, remoxipride HCl, remoxipride hydrochloride
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Remoxipride is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1990. DrugCentral lists 10 molecular targets, including SIGMAR1, DRD3 and DRD2.
- Molecular targets: SIGMAR1, DRD3, DRD2 and DRD2 (10 listed in DrugCentral).
- ATC code: N05AL04 (Benzamides).
- Molecular formula: C16H23BrN2O3; molecular weight 371.27 g/mol.
Mechanism & targets
Molecular targets (10)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Sigma non-opioid intracellular receptor 1 | SIGMAR1 | unknown | Ki 7.26 |
| D(3) dopamine receptor | DRD3 | unknown | Ki 7.16 |
| D(2) dopamine receptor | DRD2 | unknown | Ki 6.06 |
| D(2) dopamine receptor | DRD2 | antagonist | IC50 6.06 |
| D(2) dopamine receptor | Drd2 | unknown | IC50 5.85 |
| Dopamine receptor | Drd1|Drd3|Drd5|Drd4|Drd2 | unknown | IC50 5.80 |
| 5-hydroxytryptamine receptor 2A | HTR2A | unknown | Ki 5.51 |
| D(4) dopamine receptor | DRD4 | unknown | Ki 5.41 |
| 5-hydroxytryptamine receptor 1A | HTR1A | unknown | Kd 5.40 |
| D(3) dopamine receptor | DRD3 | unknown | Ki 5.34 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1990-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N05AL04 | NERVOUS SYSTEM › PSYCHOLEPTICS › ANTIPSYCHOTICS › Benzamides |
Chemical structure
| Molecular formula | C16H23BrN2O3 |
|---|---|
| Molecular weight | 371.27 g/mol |
| CAS number | 80125-14-0 |
| InChIKey | GUJRSXAPGDDABA-NSHDSACASA-N |
| PubChem CID | 54477 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Remoxipride work?
Its molecular targets in DrugCentral include SIGMAR1, DRD3, DRD2 and DRD2 (antagonist).
When was Remoxipride first approved?
Remoxipride was first approved by the YEAR INTRODUCED in 1990.
What is the chemical formula of Remoxipride?
Remoxipride has the molecular formula C16H23BrN2O3 and a molecular weight of 371.27 g/mol.
Browse: all drugs starting with R · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2365 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL22242 — compound record and bioactivity
- PubChem CID 54477 — chemical identifiers
- DrugBank DB00409 — drug record
- FDA UNII 0223RD59PE — substance identity
- UniProt Q99720 (SIGMAR1) — target protein
- UniProt P35462 (DRD3) — target protein
- UniProt P14416 (DRD2) — target protein
- UniProt P28223 (HTR2A) — target protein
- UniProt P21917 (DRD4) — target protein
- UniProt P08908 (HTR1A) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.